Can we really use retrospective subset analyses and surveillance, epidemiology, and end results data to drive clinical practice?
- PMID: 22851555
- DOI: 10.1200/JCO.2012.43.4746
Can we really use retrospective subset analyses and surveillance, epidemiology, and end results data to drive clinical practice?
Comment on
-
Uptake and economic impact of first-cycle colony-stimulating factor use during adjuvant treatment of breast cancer.J Clin Oncol. 2012 Mar 10;30(8):806-12. doi: 10.1200/JCO.2011.37.7499. Epub 2012 Feb 6. J Clin Oncol. 2012. PMID: 22312106 Free PMC article.
-
Wiser use of dose-dense adjuvant therapy in breast cancer.J Clin Oncol. 2012 Mar 10;30(8):772-4. doi: 10.1200/JCO.2011.40.2537. Epub 2012 Feb 6. J Clin Oncol. 2012. PMID: 22312107 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical